Literature DB >> 19625473

New real-time PCR detects prolonged norovirus excretion in highly immunosuppressed patients and children.

C Henke-Gendo1, G Harste, B Juergens-Saathoff, F Mattner, H Deppe, A Heim.   

Abstract

Noroviruses (NoV) are a major cause of epidemic nonbacterial gastroenteritis and affect all age groups worldwide. Three of five NoV genogroups, namely, genogroup I (GI), GII, and GIV, are associated with human disease. Unfortunately, these genogroups demonstrate a high degree of sequence diversity, complicating the design of pan-NoV diagnostic PCR tests. To decrease the risk of false-negative test results, we have developed a new one-step real-time TaqMan reverse transcription-PCR protocol. This protocol detects all human NoV genogroups in one reaction with a sensitivity of 400 virus genome equivalents/reaction for both GI and GII. The use of in vitro-transcribed NoV RNA as an external standard allows (semi)quantification of viral loads in samples. In a retrospective analysis of 206 stool samples from 77 patient episodes, the duration of NoV excretion and the amount of virus excreted were determined. Twenty (26.0%) of these episodes lasted longer than 10 days. Univariate risk factor analysis revealed the patient status after organ transplantation (odds ratio [OR], 7.49 [95% confidence interval, 2.06 to 28.32]; P < 0.001), immunosuppression (OR, 9.19 [95% confidence interval, 2.50 to 35.39]; P < 0.001), and age of less than 10 years (OR, 4.58 [95% confidence interval, 1.36 to 15.77]; P = 0.004) as risk factors for a NoV excretion period of more than 10 days. These findings were confirmed by time-dependent Kaplan-Meier analyses, whereas multivariate Cox regression analyses identified immunosuppression as the sole risk factor. Surprisingly, in contrast to the excretion periods, the viral loads in stools did not increase in connection with age or immunosuppressive status. This fact may be one important piece in the pattern of high-level NoV transmissibility and may have an impact on the development of transmission prevention strategies.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19625473      PMCID: PMC2738087          DOI: 10.1128/JCM.00448-09

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  30 in total

1.  Molecular epidemiology of outbreaks of gastroenteritis associated with small round structured viruses in Germany in 1997/98.

Authors:  E Schreier; F Döring; U Künkel
Journal:  Arch Virol       Date:  2000       Impact factor: 2.574

2.  Broadly reactive and highly sensitive assay for Norwalk-like viruses based on real-time quantitative reverse transcription-PCR.

Authors:  Tsutomu Kageyama; Shigeyuki Kojima; Michiyo Shinohara; Kazue Uchida; Shuetsu Fukushi; Fuminori B Hoshino; Naokazu Takeda; Kazuhiko Katayama
Journal:  J Clin Microbiol       Date:  2003-04       Impact factor: 5.948

3.  Evolution of human calicivirus RNA in vivo: accumulation of mutations in the protruding P2 domain of the capsid leads to structural changes and possibly a new phenotype.

Authors:  Mikael Nilsson; Kjell-Olof Hedlund; Margareta Thorhagen; Göran Larson; Kari Johansen; Anders Ekspong; Lennart Svensson
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

4.  Detection and characterization of norovirus outbreaks in Germany: application of a one-tube RT-PCR using a fluorogenic real-time detection system.

Authors:  M Höhne; E Schreier
Journal:  J Med Virol       Date:  2004-02       Impact factor: 2.327

5.  MEGA3: Integrated software for Molecular Evolutionary Genetics Analysis and sequence alignment.

Authors:  Sudhir Kumar; Koichiro Tamura; Masatoshi Nei
Journal:  Brief Bioinform       Date:  2004-06       Impact factor: 11.622

6.  Enteric virus infections and diarrhea in healthy and human immunodeficiency virus-infected children.

Authors:  M B Liste; I Natera; J A Suarez; F H Pujol; F Liprandi; J E Ludert
Journal:  J Clin Microbiol       Date:  2000-08       Impact factor: 5.948

7.  Evolution of poliovirus type I during 5.5 years of prolonged enteral replication in an immunodeficient patient.

Authors:  A Bellmunt; G May; R Zell; P Pring-Akerblom; W Verhagen; A Heim
Journal:  Virology       Date:  1999-12-20       Impact factor: 3.616

8.  Development of a rapid high-throughput method for high-resolution melting analysis for routine detection and genotyping of noroviruses.

Authors:  Etsuko Tajiri-Utagawa; Masayuki Hara; Kuniaki Takahashi; Mayumi Watanabe; Takaji Wakita
Journal:  J Clin Microbiol       Date:  2008-12-10       Impact factor: 5.948

9.  Natural history of human calicivirus infection: a prospective cohort study.

Authors:  Barry Rockx; Matty De Wit; Harry Vennema; Jan Vinjé; Erwin De Bruin; Yvonne Van Duynhoven; Marion Koopmans
Journal:  Clin Infect Dis       Date:  2002-07-10       Impact factor: 9.079

10.  Chronic excretion of a norovirus in a child with cartilage hair hypoplasia (CHH).

Authors:  Chris I Gallimore; David Lewis; Clive Taylor; Andrew Cant; Andrew Gennery; Jim J Gray
Journal:  J Clin Virol       Date:  2004-06       Impact factor: 3.168

View more
  25 in total

1.  An Improved One-Step Real-Time Reverse Transcription-PCR Assay for Detection of Norovirus.

Authors:  Ilona Glowacka; Gabrielle Harste; Jennifer Witthuhn; Albert Heim
Journal:  J Clin Microbiol       Date:  2015-12-04       Impact factor: 5.948

2.  The role of chronic norovirus infection in the enteropathy associated with common variable immunodeficiency.

Authors:  Jeremy M Woodward; Effrossyni Gkrania-Klotsas; Anthony Yk Cordero-Ng; Aloysious Aravinthan; Betty N Bandoh; Hongxiang Liu; Susan Davies; Hongyi Zhang; Philip Stevenson; Martin D Curran; Dinakantha Kumararatne
Journal:  Am J Gastroenterol       Date:  2015-01-27       Impact factor: 10.864

Review 3.  The role of prolonged viral gastrointestinal infections in the development of immunodeficiency-related enteropathy.

Authors:  Annick A J M van de Ven; David P Hoytema van Konijnenburg; Annemarie M J Wensing; Joris M van Montfrans
Journal:  Clin Rev Allergy Immunol       Date:  2012-02       Impact factor: 8.667

4.  Environmental detection of genogroup I, II, and IV noroviruses by using a generic real-time reverse transcription-PCR assay.

Authors:  Takayuki Miura; Sylvain Parnaudeau; Marco Grodzki; Satoshi Okabe; Robert L Atmar; Françoise S Le Guyader
Journal:  Appl Environ Microbiol       Date:  2013-08-16       Impact factor: 4.792

5.  Pattern of circulation of norovirus GII strains during natural infection.

Authors:  James Ayukepi Ayukekbong; Cajetan Fobisong; Ferdinand Tah; Magnus Lindh; Theresia Nkuo-Akenji; Tomas Bergström
Journal:  J Clin Microbiol       Date:  2014-10-01       Impact factor: 5.948

6.  Defining the causes of diarrhea: novel approaches.

Authors:  Darwin J Operario; Eric Houpt
Journal:  Curr Opin Infect Dis       Date:  2011-10       Impact factor: 4.915

7.  Unrecognized norovirus infections in health care institutions and their clinical impact.

Authors:  Matthias F C Beersma; Faizel H A Sukhrie; Jolanda Bogerman; Linda Verhoef; Mariana Mde Melo; Alieke G Vonk; Marion Koopmans
Journal:  J Clin Microbiol       Date:  2012-07-11       Impact factor: 5.948

Review 8.  The burden of norovirus gastroenteritis: an important foodborne and healthcare-related infection.

Authors:  G Belliot; B A Lopman; K Ambert-Balay; P Pothier
Journal:  Clin Microbiol Infect       Date:  2014-08       Impact factor: 8.067

Review 9.  Norovirus in Transplantation.

Authors:  Michael P Angarone; Anna Sheahan; Mini Kamboj
Journal:  Curr Infect Dis Rep       Date:  2016-06       Impact factor: 3.725

10.  Norovirus gastroenteritis in immunocompromised patients.

Authors:  Sarah Haessler; Eric V Granowitz
Journal:  N Engl J Med       Date:  2013-03-07       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.